Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Thursday, May 30, 2024 | Back issues
Courthouse News Service Courthouse News Service

Shareholder Class Action

MANHATTAN - BioScrip stock lost $210 million in market capitalization when its directors' misrepresentations were revealed in September, shareholders claim in a federal class action.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...